Skip to content
TrialScanner

NCT01188577

Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics

Phase 1/Phase 2CompletedAMPHLead

Registry record

Lead sponsor
Amphastar Pharmaceuticals, Inc.
Conditions
Asthma; Bronchospasm; Wheezing; Shortness of Breath
Primary completion
Sep 2010Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01188577 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01188577: Epinephrine Inhalation... | TrialScanner